SERPINB5 and colorectal cancer: In another study of 243 stage II and 176 stage III colorectal cancers, maspin expression was differentially expressed in liver metastasis with early vs. prolonged time to recurrence after resection and was an independent predictor of time to recurrence and CRC-specific survival in stage III patients, but high expression did not correlate with survival in stage II patients (20).